Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ovarian Neoplasms

Free Subscription 15.07.2019 1 Am J Obstet Gynecol 1 Am J Surg Pathol 1 Cancer Lett 1 Clin Cancer Res 1 Gynecol Oncol 1 J Natl Cancer Inst 2 Lancet Oncol 3 Oncogene 1 Oncology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Obstet Gynecol

1. TARNEY CM, Wang G, Bateman NW, Conrads KA, et al
   Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
   Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30769.
   PubMed     Text format     Abstract available
   
   

   
   Am J Surg Pathol

2. 
   Ovarian Microcystic Stromal Tumors are Characterized by Alterations in the Beta-Catenin-APC Pathway and May be an Extracolonic Manifestation of Familial Adenomatous Polyposis.
   Am J Surg Pathol. 2017 Oct 26. doi: 10.1097/PAS.0000000000000981.
   PubMed     Text format    
   
   

   
   Cancer Lett

3. PARAYATH NN, Gandham SK, Leslie F, Amiji MM, et al
   Improved anti-tumor efficacy of paclitaxel in combination with MicroRNA-125b-based tumor-associated macrophage repolarization in epithelial ovarian cancer.
   Cancer Lett. 2019;461:1-9.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

4. LI Z, Zhou W, Zhang Y, Sun W, et al
   ERK regulates HIF-1alpha-mediated platinum resistance by directly targeting PHD2 in ovarian cancer.
   Clin Cancer Res. 2019 Jul 8. pii: 1078-0432.CCR-18-4145.
   PubMed     Text format     Abstract available
   
   

   
   Gynecol Oncol

5. MATSUO K, Huang Y, Zivanovic O, Shimada M, et al
   Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.
   Gynecol Oncol. 2019 Jul 3. pii: S0090-8258(19)31337.
   PubMed     Text format     Abstract available
   
   

   
   J Natl Cancer Inst

6. TOMAO F, Panici PB, Tomao S
   RE: Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
   J Natl Cancer Inst. 2019 Jul 9. pii: 5530203. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Lancet Oncol

7. NENE NR, Reisel D, Leimbach A, Franchi D, et al
   Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.
   Lancet Oncol. 2019 Jul 9. pii: S1470-2045(19)30340.
   PubMed     Text format     Abstract available
   
   
8. VERSTRAELEN H
   Of microbes and women: BRCA1, vaginal microbiota, and ovarian cancer.
   Lancet Oncol. 2019 Jul 9. pii: S1470-2045(19)30406.
   PubMed     Text format    
   
   

   
   Oncogene

9. HARDY LR, Pergande MR, Esparza K, Heath KN, et al
   Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
   Oncogene. 2019 Jul 11. pii: 10.1038/s41388-019-0842.
   PubMed     Text format     Abstract available
   
   
10. CHEN X, Mangala LS, Mooberry L, Bayraktar E, et al
    Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.
    Oncogene. 2019 Jul 9. pii: 10.1038/s41388-019-0862.
    PubMed     Text format     Abstract available
    
    
11. MAJEM B, Parrilla A, Jimenez C, Suarez-Cabrera L, et al
    MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.
    Oncogene. 2019 Jul 5. pii: 10.1038/s41388-019-0860.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

12. MARKMAN M
    The Evolving Arena of Ovarian Cancer Maintenance Therapy.
    Oncology. 2019 Jul 9:1-4. doi: 10.1159/000501618.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: